




Searching News Database: Pharmion
HSMN NewsFeed - 2 Apr 2019
Petra Pharma Strengthens Management Team with Recent Leadership Appointments
Petra Pharma Strengthens Management Team with Recent Leadership Appointments
HSMN NewsFeed - 17 Dec 2015
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
HSMN NewsFeed - 7 Jul 2015
Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners
Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners
HSMN NewsFeed - 12 May 2015
Autonomic Technologies Raises USD 38M in a Transatlantic Series D Financing
Autonomic Technologies Raises USD 38M in a Transatlantic Series D Financing
HSMN NewsFeed - 16 Oct 2013
Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO
Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO
HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
HSMN NewsFeed - 7 Jan 2009
Sangart, Inc. Announces Key Executive Appointments and Company Restructuring
Sangart, Inc. Announces Key Executive Appointments and Company Restructuring
HSMN NewsFeed - 4 Sep 2008
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
HSMN NewsFeed - 7 Aug 2008
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
HSMN NewsFeed - 25 Mar 2008
Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer
Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer
HSMN NewsFeed - 25 Feb 2008
GPC Biotech Announces Corporate Restructuring and Provides Pipeline Update
GPC Biotech Announces Corporate Restructuring and Provides Pipeline Update
HSMN NewsFeed - 30 Oct 2007
GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial
GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial
HSMN NewsFeed - 17 Oct 2007
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
HSMN NewsFeed - 10 Oct 2007
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
HSMN NewsFeed - 29 Aug 2007
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
HSMN NewsFeed - 27 Jul 2007
Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines Agency
Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines Agency
HSMN NewsFeed - 26 Jun 2007
GPC Biotech Announces that Partner Pharmion Submits European Marketing Application for Satraplatin
GPC Biotech Announces that Partner Pharmion Submits European Marketing Application for Satraplatin
HSMN NewsFeed - 25 Jun 2007
GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult
GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult
HSMN NewsFeed - 2 Jun 2007
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
HSMN NewsFeed - 16 Apr 2007
FDA Accepts GPC Biotech's Satraplatin NDA for Filing and Grants Priority Review Status
FDA Accepts GPC Biotech's Satraplatin NDA for Filing and Grants Priority Review Status
HSMN NewsFeed - 22 Mar 2007
Satraplatin Phase 3 SPARC Trial - Additional Data Presented at European Association of Urology Congress
Satraplatin Phase 3 SPARC Trial - Additional Data Presented at European Association of Urology Congress
HSMN NewsFeed - 22 Mar 2007
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
HSMN NewsFeed - 14 Mar 2007
Tragara Pharmaceuticals, Inc. Announces Corporate Launch and Series A Financing
Tragara Pharmaceuticals, Inc. Announces Corporate Launch and Series A Financing
HSMN NewsFeed - 21 Feb 2007
GPC Biotech Launches Expanded Access Program for Oncology Drug Candidate Satraplatin in the U.S.
GPC Biotech Launches Expanded Access Program for Oncology Drug Candidate Satraplatin in the U.S.
HSMN NewsFeed - 29 Jan 2007
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
HSMN NewsFeed - 11 Dec 2006
New Data Validate Vidaza(R) Response Rates in MDS and Report Results in AML
New Data Validate Vidaza(R) Response Rates in MDS and Report Results in AML
HSMN NewsFeed - 21 Nov 2006
Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan
Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan
HSMN NewsFeed - 1 Nov 2006
Pharmion Corporation Announces Enrollment of First Patient Into Vidaza(R) Patient Registry
Pharmion Corporation Announces Enrollment of First Patient Into Vidaza(R) Patient Registry
HSMN NewsFeed - 12 Oct 2006
Favrille Appoints Former Eli Lilly Executive Michael Eagle Chairman of the Board
Favrille Appoints Former Eli Lilly Executive Michael Eagle Chairman of the Board
HSMN NewsFeed - 8 Jun 2006
Independent Data Monitoring Board Recommends That Satraplatin Phase 3 Trial Continue as Planned
Independent Data Monitoring Board Recommends That Satraplatin Phase 3 Trial Continue as Planned
HSMN NewsFeed - 25 Apr 2006
Independent Data Monitoring Board Recommends That Satraplatin Phase 3 Trial Continue as Planned
Independent Data Monitoring Board Recommends That Satraplatin Phase 3 Trial Continue as Planned
HSMN NewsFeed - 30 Mar 2006
Pharmion Corporation Announces Submission of Vidaza NDA Supplement for IV Administration
Pharmion Corporation Announces Submission of Vidaza NDA Supplement for IV Administration
Additional items found! 21

Members Archive contains
21 additional stories matching:
Pharmion
(Password required)
Pharmion
(Password required)